Pfizer cherry-picks cancer drug rights from Merck

Source: Pano feed

Bloomberg Intelligence’s Sam Fazeli reports on a deal between Merck and Pfizer over the rights to a possible cancer drug. He speaks with Jonathan Ferro on Bloomberg Television’s “On The Move.”




Đăng ký: VietNam News

Related Posts